US IVF & Fertility Marketing Benchmark 2026
CPC and CAC by mandate versus non-mandate state, employer-benefit funnel conversion (Progyny, Carrot, Maven Clinic, WINFertility), LGBTQ+ family-building funnel performance, donor and surrogate pathway benchmarks, single versus multi-cycle package share, and impact modelling for the SB 729 California mandate expansion and the IL Family Building Act. The 2026 US fertility operating dataset from Ichelon Consulting US.
The five things US fertility marketing looks like in 2026
- Non-mandate-state IVF Google Ads CPC in 2026 averages $18 to $34 per click across the top 15 US fertility metros, with mandate-state IVF CPC running materially lower ($9 to $17) because the search intent skews toward provider-selection under existing coverage rather than the more competitive under-what-package cash-pay search intent that dominates non-mandate states.
- Non-mandate-state IVF CAC in 2026 averages $580 to $1,240 per new patient consultation, materially higher than mandate-state CAC ($240 to $520). The gap reflects the longer consideration cycle, package-pricing-shopping behaviour, and financing-decision friction present in cash-pay-heavy non-mandate markets and largely absent in mandate-heavy markets.
- Employer-benefit acceptance messaging (Progyny in-network, Carrot in-network, Maven Clinic in-network, WINFertility in-network landing pages) lifts conversion by 28 to 46 percent in high-tech-employer metros (San Francisco Bay Area, Puget Sound, Austin, Denver, Boston, Manhattan) where the covered-life share of the addressable market is meaningful. Metros with lower tech-employer share see smaller lift (12-22 percent) but still positive.
- LGBTQ+ family-building funnel conversion in metros with high LGBTQ+ population share (Portland, San Francisco Bay Area, Manhattan, Miami Beach, Washington DC, Chicago) runs 12 to 22 percent of total fertility funnel volume, materially above the 4 to 8 percent share these funnels typically capture when marketing is not scoped to pathway-specific creative. Metros without LGBTQ+-specific funnel design forfeit a meaningful share of the addressable market.
- California SB 729 (2024 mandate expansion) and the IL Family Building Act (2023 mandate expansion) will materially reshape 2026 and 2027 CAC and CPC dynamics in California and Illinois as newly-covered patient populations enter the fertility funnel. Ichelon Consulting US's impact modelling suggests CAC in CA will move materially lower (toward existing mandate-state levels) over the 24 months following full implementation.
Cite this report
Inline HTML:
Ichelon Consulting US. (2026). US IVF & Fertility Marketing Benchmark 2026. Retrieved from https://ichelonconsulting.com/reports/us-ivf-fertility-marketing-benchmark-2026
APA 7:
Reddy, S. (2026, September). US IVF & Fertility Marketing Benchmark 2026: Mandate + Employer-Benefit CPC and CAC. Ichelon Consulting US. https://ichelonconsulting.com/reports/us-ivf-fertility-marketing-benchmark-2026
Licensed under Creative Commons Attribution 4.0 (CC BY 4.0). Reproduce, share, adapt freely with attribution.
Methodology and data sources
The 2026 US IVF and Fertility Marketing Benchmark aggregates first-party Ichelon Consulting US fertility client marketing data across the January to August 2026 observation window (14 fertility clinics in the client base distributed across mandate and non-mandate states); public search-behaviour signals; and third-party Google Ads CPC data. All figures are aggregate — no individual clinic, patient, or engagement-specific data is reported.
Metro selection: top 15 US fertility metros by fertility-Google-search-volume — New York, Los Angeles, Chicago, San Francisco Bay Area, Boston, Washington DC, Philadelphia, Dallas-Fort Worth, Houston, Miami, Atlanta, Phoenix, Seattle, Portland, Denver. Split: mandate-state metros (NY-NYC, IL-Chicago post-Family-Building-Act, CA-SF-Bay-and-LA post-SB-729, MA-Boston, NJ-northern-NJ, CO-Denver post-Building-Families-Act) versus non-mandate-state metros (TX-Dallas-Houston-Austin, FL-Miami, GA-Atlanta, AZ-Phoenix, WA-Seattle partial, OR-Portland, DC-DMV partial).
Mandate-state vs non-mandate-state CPC benchmarks
Mandate-state IVF Google Ads CPC averages $9 to $17 per click across the sample; non-mandate-state IVF CPC averages $18 to $34. The gap reflects underlying search-intent differences. In mandate states, the fertility patient arrives at Google already knowing insurance covers the cycle and searches primarily for provider selection ("best IVF clinic in Chicago," "top rated fertility specialist NYC"). In non-mandate states the patient is comparing packages, evaluating cash-pay pricing, and researching financing options, which drives higher competitive bidding on price-and-package-oriented keywords.
| Metro | Mandate? | IVF CPC | IVF CAC |
|---|---|---|---|
| San Francisco Bay Area | Yes (SB 729) | $16.20 | $480 |
| Los Angeles | Yes (SB 729) | $15.80 | $460 |
| New York (NYC) | Yes | $14.90 | $420 |
| Boston | Yes | $13.60 | $390 |
| Chicago | Yes (IL FBA) | $12.40 | $350 |
| Washington DC | Partial (FEHB) | $14.20 | $540 |
| Denver | Yes (CO BFA) | $10.80 | $310 |
| Philadelphia | Partial (NJ side) | $11.20 | $620 |
| Miami | No | $28.40 | $980 |
| Atlanta | No | $22.10 | $780 |
| Dallas-Fort Worth | No | $21.60 | $750 |
| Houston | No | $20.80 | $720 |
| Austin | No | $26.30 | $920 |
| Phoenix | No | $18.40 | $680 |
| Seattle | Partial | $17.90 | $580 |
| Portland | No | $16.20 | $620 |
Employer-benefit funnel conversion — Progyny, Carrot, Maven Clinic, WINFertility
Employer-benefit third-party administrator acceptance messaging materially lifts conversion in metros with high tech-employer or corporate-HQ density. Practices that build benefit-name-specific landing pages ("Progyny in-network fertility clinic in Austin," "Carrot in-network fertility clinic Seattle Eastside") and surface acceptance in the six-placement empanelment-surfacing framework capture 28 to 46 percent higher conversion in high-tech-employer metros compared to practices that surface only generic in-network status.
Lift is highest in Puget Sound (Amazon Progyny + Microsoft Carrot + Boeing Progyny + Costco Progyny concentration), San Francisco Bay Area (multiple tech-employer Progyny and Carrot benefits), Austin (Tesla Carrot + Apple Progyny + Oracle + Dell + Meta + Google Carrot concentration), Manhattan (finance-industry Progyny and Carrot benefits), and Boston (biotech Progyny concentration). Lower-tech-employer metros (San Antonio, Charlotte, Nashville, Portland) still see positive lift but at 12 to 22 percent range.
LGBTQ+ family-building funnel performance
LGBTQ+ family-building funnels in metros with high LGBTQ+ population share (Portland, San Francisco Bay Area, Manhattan, Miami Beach, Washington DC, Chicago) run 12 to 22 percent of total fertility funnel volume when marketing is scoped to pathway-specific creative (reciprocal IVF, sperm-donor selection walkthroughs, gestational surrogacy explainers, trans and non-binary fertility preservation). Metros without LGBTQ+-specific funnel design typically capture 4 to 8 percent of the same population share — meaning meaningful addressable market is forfeited by generic family-building creative.
Portland leads the sample at 22 percent LGBTQ+ funnel share (reflecting the highest US metro LGBTQ+ population share). San Francisco Bay Area, Manhattan, and Miami Beach follow at 16 to 20 percent. DC, Chicago, and Boston sit at 12 to 16 percent. Non-coastal-metro clinics under-invest in this funnel meaningfully — Denver, Atlanta, Austin, and Seattle all carry LGBTQ+ addressable market larger than typical clinic marketing captures.
Donor and surrogate pathway conversion benchmarks
Donor-egg pathway funnel conversion (initial consultation booking to donor-cycle commitment) runs 6 to 14 percent depending on state, pricing transparency, and donor-database access quality. Donor-sperm funnel conversion runs higher (10 to 20 percent) reflecting lower financial commitment per cycle. Embryo-donation funnel is smaller volume but higher conversion (12 to 18 percent) reflecting the specific patient population that seeks that pathway.
Gestational surrogacy funnel conversion is dominated by state legal-landscape variance. Surrogacy-friendly states with codified pre-birth-order pathways (California, Illinois, Washington, Colorado, Nevada, Florida, Texas with procedural constraints) see meaningful surrogacy funnel volume; surrogacy-restrictive states (Michigan, Louisiana, historically Nebraska) see minimal. Cross-state surrogacy — intended parents in a restrictive state pursuing surrogacy with a gestational carrier in a permissive state — accounts for a growing share of the surrogacy funnel and shifts marketing to a cross-state framing.
Single vs multi-cycle package share benchmarks
Single-cycle package selection dominates the mandate-state fertility funnel (approximately 70 to 82 percent of covered-patient package selection in the sample) because coverage typically pays per-cycle up to a state-defined maximum. Multi-cycle package selection dominates the non-mandate cash-pay funnel (approximately 55 to 68 percent of cash-pay package selection) because the shared-risk-or-refund framing meaningfully changes the buyer's mental model — from "can I afford one cycle" to "what happens if it takes more than one."
Fertility preservation (elective egg-freezing) funnel benchmarks
Elective egg-freezing (fertility preservation for social or medical reasons) has continued to grow as a cash-pay funnel share of total fertility marketing volume. Employer-benefit coverage of elective egg-freezing has expanded meaningfully through Progyny, Carrot, and Maven Clinic offerings, which shifts elective preservation from pure-cash-pay to hybrid-covered-plus-cash-pay in the tech-employer covered-lives base. Marketing implication: elective egg-freezing funnels should surface employer-benefit acceptance alongside CareCredit and Future Family financing, and the funnel design differs materially for the covered patient versus the pure-cash-pay patient.
SB 729 California, IL Family Building Act, FEHB IVF expansion — impact modelling
Three recent mandate expansions materially reshape 2026 and 2027 fertility marketing dynamics.
California SB 729 (2024 mandate expansion): Expands commercial insurance coverage for fertility diagnosis and treatment including IVF across large-group commercial plans, effective for plan years beginning in 2025 and later. Ichelon Consulting US's impact modelling suggests California CAC will move materially lower over the 24 months following full implementation as the newly-covered patient population enters the funnel with mandate-state search-intent patterns rather than cash-pay-shopping patterns. CPC will move lower on cash-pay-oriented keywords and higher on provider-selection keywords.
Illinois Family Building Act (2023 mandate expansion): Expanded IL fertility coverage requirements. The 2023-through-2026 window has been the transition period as covered-patient populations activate benefits and enter the fertility funnel. IL CAC has already moved materially lower in the sample compared to pre-2023 baseline.
FEHB IVF expansion (2024): The Federal Employees Health Benefits programme expanded IVF coverage for eligible federal employees. Impact is concentrated in DC-DMV, Maryland-Virginia, and metros with substantial federal-employee populations. Practices serving these metros should audit FEHB acceptance surfacing and build federal-employee-scoped landing content.
Multilingual creative lift benchmarks
Spanish-paired creative lifts fertility CAC by 18 to 32 percent in Latinx-heavy metros. Miami (Spanish-first market) delivers highest lift. Portuguese creative in Miami-Aventura and Boston-Cambridge Brazilian-American concentrations delivers meaningful lift. Mandarin and Cantonese creative in Bay Area, Los Angeles, Seattle Eastside, and Queens NY delivers lift. Practices marketing to these catchments in English only forfeit conversion equivalent to the lift figure.
2026 forecast and strategic recommendations
The 2026 US fertility market is characterised by expanding mandate coverage (California SB 729, IL Family Building Act, potential 2027 state-level expansions in additional states), growing employer-benefit third-party administrator adoption particularly in tech and biotech, continued LGBTQ+ funnel share growth as generational demographic shift continues, elective egg-freezing category growth (both cash-pay and employer-covered), and AI-search-driven marketing changes as AI Overview citations become meaningful for fertility-condition and fertility-package queries. Practices that invest in employer-benefit landing families, LGBTQ+ pathway-specific creative, donor and surrogate pathway content depth, and multilingual creative for demographic-appropriate catchments will be positioned for the 2027 competitive landscape.
Related reports and playbooks
-
Primary Care · North Dallas, TXCase study →
-
MedSpa · North Dallas, TX
-
Skin Care · Beverly Hills, CA
-
Dental · Christiansburg, VACase study →
-
Pediatrics · Blacksburg, VACase study →
-
Pediatric Dentistry · Blacksburg, VACase study →
-
Dental · Roanoke, VACase study →
-
Functional Medicine · Telehealth · USACase study →
“They were able to get all my ideas and work with me over a period of three to four months and create this amazing website. It's super customized, very modern, and it incorporates all the elements that I had wanted — the patient portal, nice pictures, a very interactive website, patient reviews. I would highly recommend their company to anyone who wants to make an excellent website.”